12:00 AM
 | 
Mar 06, 2000
 |  BC Week In Review  |  Company News  |  Other News

Progenics other research news

PGNX said that it identified synthetic sulfated peptides derived from the HIV co-receptor CCR5 that blocked the binding of HIV to cell...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >